반응식
[CH:1]1[CH:2]=[CH:3][C:4]2[N:15]([C:16]([NH2:18])=[O:17])[C:14]3[CH:13]=[CH:12][CH:11]=[CH:10][C:9]=3[CH:8]=[CH:7][C:5]=2[CH:6]=1.[CH:19]1[C:24]([CH:25]=[O:26])=[CH:23][CH:22]=[C:21]([CH:27]=[O:28])[CH:20]=1>CO>[CH:11]1[CH:12]=[CH:13][C:14]2[N:15]([C:16]([NH2:18])=[O:17])[C:4]3[CH:3]=[CH:2][CH:1]=[CH:6][C:5]=3[CH:7]=[CH:8][C:9]=2[CH:10]=1.[CH:23]1[C:24]([CH:25]=[O:26])=[CH:19][CH:20]=[C:21]([CH:27]=[O:28])[CH:22]=1참가 물질
4
실험 절차
25 mg (0.1058 mmol) carbamazepine and 7 mg (0.0521 mmol) p-phthalaldehyde were dissolved in approximately 3 mL methanol. Slow evaporation of the solvent yielded colorless needles of a 1:1 carbamazepine/p-phthalaldehyde co-crystal, as shown in FIG. 50A-B.
후처리
- customevaporation of the solvent
출처 및 근거
- ORD 기록
- ord-5dfa08e8a2384fe099b1d551c8fdab9f
- 출처 데이터셋
- uspto-grants-2011_04
- 특허 번호
- US07927613B2
연결된 노트
불러오는 중…